Topical Application of BMX-010 in Subjects With Atopic Dermatitis and Plaque Psoriasis

NCT03381625 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

139

Enrollment

INDUSTRY

Sponsor class

Conditions

Psoriasis
Atopic Dermatitis

Interventions

DRUG: BMX-010
DRUG: Placebo

Sponsor

BioMimetix JV, LLC